Grade 2). Furthermore, because of the very low quality of the underlying evidence,
the details of these recommendations are likely to change
as better-quality evidence becomes available. In this
regard, the use of patient-important outcomes, such as
quality of life or objective measures of the post-thrombotic syndrome (Villalta score,102 Venous Clinical Severity Score103) should be strongly encouraged over technical outcomes such as lytic success and surrogate
markers such as